Cornell’s Research
Serves the Region and Beyond

Ionica Sciences

R&D: Biotechnology

Ionica Sciences has developed an adaptable, sensitive, and easy-to-use platform for the detection of infectious and other diseases. The platform uses surface-enhanced Raman scattering, combined with DNA aptamers, to detect proteins and other antigens associated with human disease. The company's current focus is on the development of a new, high sensitivity test for Lyme disease in humans.

Cornell Connection

The company is a tenant in the Kevin M. McGovern Family Center for Venture Development in the Life Sciences.